Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

First population-based food allergy study explores racial and ethnic differences in all age groups

Food allergy has not been on the radar of most racial and ethnic communities. But a new Northwestern Medicine study -; the first population-based food allergy study in the U.S. to explore racial and ethnic differences in all age groups -; shows why it should be.

14 Jun 2023

New research could one day make common allergies a thing of the past

For years, research and therapies for allergic asthma have been focused largely on targeting the inflammatory cytokines in the body that react to allergens and cause overproduction of mucus, wheezing and difficulty breathing.

14 Jun 2023

Vaginal seeding engrafts maternal bacteria in the bodies of cesarean section born neonates

Newborns delivered by cesarean section who are swabbed with the vaginal fluid of their mothers after birth have beneficial bacteria restored to their skin surface and stools, according to a new study.

14 Jun 2023

From delicacy to danger: The rising tide of shellfish allergies in children revealed

Shellfish consumption is on the rise, but so are shellfish allergies, particularly among children. A recent review delves into the epidemiology, symptoms, diagnosis, and management of shellfish allergies, highlighting the need for improved diagnostic tools and potential allergen immunotherapy.

13 Jun 2023

Immune resilience promotes longevity and resistance to infections

Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress -; called "immune resilience" -; differs widely among individuals.

13 Jun 2023

Study reveals biologically validated imaging-based evidence of medically induced myelin repair

A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in repairing the brain, making it possible to also assess future therapies for the devastating disorder.

13 Jun 2023

Study suggests the role of histamine-releasing factor in severe asthma and RV-induced asthma exacerbation

Asthma is more dangerous than many people realize. An estimated 10 Americans die everyday from asthma, and the disease leads to around 439,000 hospitalizations and 1.3 million emergency room trips each year.

12 Jun 2023

Sebum RNA could provide reliable biomarkers for detecting early-onset atopic dermatitis

Eczema is an inflammatory skin condition that often affects infants as young as one to two months. Among the various types of eczema seen in infants, early-onset atopic dermatitis (AD), characterized by psychological stress and sleep disorders, is particularly concerning.

8 Jun 2023

Nuts for the brain: Study shows nut consumption boosts memory and brain health in seniors

Long-term consumption of mixed nuts in older adults improves brain vascular function and may enhance cognitive performance. The study highlights the potential benefits of nut consumption for brain health in aging populations.

6 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Scientists investigate how immune system's T cells could fight many coronaviruses at once

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system's T cells react to a wide variety of coronaviruses, ranging from SARS to common cold coronaviruses.

1 Jun 2023

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

31 May 2023

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

St. Jude Children's Research Hospital scientists discovered how the current epizootic H5N1 avian influenza virus (bird flu) gained new genes and greater virulence as it spread west.

30 May 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

Study shows how IgA acts as a "tuner" to keep the immune system in check

IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers.

26 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

$Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride$

Allergy News and Research

Further Reading

First population-based food allergy study explores racial and ethnic differences in all age groups

New research could one day make common allergies a thing of the past

Vaginal seeding engrafts maternal bacteria in the bodies of cesarean section born neonates

From delicacy to danger: The rising tide of shellfish allergies in children revealed

Immune resilience promotes longevity and resistance to infections

Study reveals biologically validated imaging-based evidence of medically induced myelin repair

Study suggests the role of histamine-releasing factor in severe asthma and RV-induced asthma exacerbation

Sebum RNA could provide reliable biomarkers for detecting early-onset atopic dermatitis

Nuts for the brain: Study shows nut consumption boosts memory and brain health in seniors

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Scientists investigate how immune system's T cells could fight many coronaviruses at once

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Genetic change supercharged spread and severity of epizootic H5N1 avian influenza virus

New method may help identify the essential ingredients for making an effective HIV vaccine

Study shows how IgA acts as a "tuner" to keep the immune system in check

MHRA authorizes new COVID-19 vaccine from SK Chemicals

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride

Study shows the potential of TAp63 as a new therapeutic target for rheumatoid arthritis

Mouse study offers clues to developing an effective vaccine for Klebsiella bacteria

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News